drugset / Trial / NCT02816853

Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Chinese Healthy Participants

NCT02816853

Phase 1 Completed 44 enrolled Janssen Research & Development, LLC
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to assess the effects of domperidone on the QTc interval duration in Chinese healthy adult participants after multiple domperidone doses of 10 milligram (mg) 3 times a day (tid) and 20 mg tid.

Timeline

Start
2016-05
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Domperidone Unknown 10 mg
Subject Domperidone Unknown 20 mg
Subject Moxifloxacin Small molecule 400 mg

Indications

No indication recorded.